Key result
Sildenafil increases arterial oxygen saturation within the first hour in Fontan patients.
Why the study?
A misprint in the cardiac output formula and comments regarding shunt calculation and pulmonary blood flow measurement in Fontan patients after sildenafil administration prompted this reply.
This reply clarifies the formula for calculating cardiac output and explains how the Innocor nitrous oxide re-breathing system estimates intrapulmonary shunting and pulmonary blood flow in Fontan patients treated with sildenafil.
Answers are grounded in this paper and cite their sources.
Supports acute oxygenation benefit of sildenafil in Fontan patients; leaves open validation of 98% end-capillary shunt estimation.
Hager et al.1 have to be thanked for pointing out that there is a misprint in the formula for the calculation of cardiac output. Indeed, the formula should read: cardiac output =1/[(arterial O2 content – pulmonary end-capillary O2 content)/oxygen uptake + 1/pulmonary blood flow].2 The use of pulmonary end-capillary O2 content indeed allows the Innocor™ system to calculate the amount of right-to-left shunt, assuming end-capillary O2 saturation to be equal to 98%. In Fontan patients, the presence of arterial desaturation is usually consequent to the right-to-left shunt because of either a fenestration between the Fontan circuit and the systemic atrium or pulmonary arterio-venous fistulas (anatomical or functional related to ventilation/perfusion mismatch). However, the Innocor™ system is unable to distinguish at which level the right-to-left shunt occurs. In this setting, the knowledge of pulmonary venous saturation allows us to estimate the site and relative contribution of intrapulmonary or intra-cardiac shunting to arterial desaturation (at pulmonary veins level versus at systemic atrial level). This is particularly important as pulmonary vasodilators can theoretically increase the flow in lung areas with reduced ventilation, potentially worsening arterial saturation. In the referred study,1 an increase in arterial O2 saturation in the first hour after sildenafil administration was observed. Since the effect of sildenafil on intra-cardiac right-to-left shunt is likely to be marginal because of the restrictive nature of the fenestration (4 mm in diameter), and since pulmonary blood flow and cardiac output are known, it is possible to estimate the amount of intrapulmonary shunt after sildenafil administration, and to assess its change from baseline. Of course, this calculation does not pretend to be an accurate measurement, but rather a general guide into the potential effects of sildenafil in this population. Furthermore, as Hager et al. have pointed out, Fontan patients have a ventilation/perfusion mismatch, which could be anatomical (pulmonary arterio-venous fistulas) or functional. However, contrary to what they suggest, predicting whether and how pulmonary blood flow measurement is affected by the ventilation/perfusion mismatch when using nitrous oxide dilution technique should not be difficult. Indeed, the Innocor™ system, using re-breathing technique, measures only pulmonary blood flow that is directed to ventilated alveoli. Lung areas with abnormal/no ventilation and preserved perfusion will produce shunting of deoxygenated blood into the systemic circulation. On the other hand, lung areas with preserved ventilation and reduced perfusion will contribute to nitrous oxide washout only to an extent proportional to the amount of regional pulmonary blood flow.
No takes yet. Share an insight, caveat, or question.
Anna Giardini (2008) conducted a letter in Fontan patients. sildenafil was evaluated. Sildenafil administration increased arterial O2 saturation in the first hour in Fontan patients, and intrapulmonary shunting can be estimated assuming a 98% end-capillary O2 saturation.
Synapse has enriched 10 related papers. Consider them for comparative context: